Indefinite Delivery Contract SPE2DE22D0017

Award Date 3/4/22
Last Date to Order 9/3/23
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency Troop Support Medical awarded a $49,000,000.00 single-award Indefinite Delivery Contract (IDC), contract number SPE2DE22D0011, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract provides for the continuous delivery of reagents, diagnostic test kits, equipment, and associated maintenance services to support clinical testing programs across various federal agencies, including the Department of Veterans Affairs, Department of Health...
The Department of the Army Medical Command awarded a single award indefinite delivery contract to Cepheid with a potential value of $9,885,354.74 to provide SARS-CoV-2/influenza polymerase chain reaction diagnostic testing. Under this contract vehicle, the agency issued a firm fixed price delivery order worth $1,404,461.44 to Cepheid for SARS-CoV-2/influenza PCR testing services to be performed at Fort Sam Houston, Texas from October 1, 2023 through September 30, 2024. The originating...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded an Indefinite Delivery Contract to Cepheid, a subsidiary of Danaher Corporation, with a potential value of $495,000,000.00. The contract aims to procure diagnostic systems, assays, and related services to support the agency's chemical and biological defense programs. Under the contract, Cepheid has received multiple task orders for COVID-19 and Ebola diagnostic testing supplies and...
The Department of the Army Medical Command awarded a single award Indefinite Delivery Contract to Cepheid of Sunnyvale, California for SARS-COV-2 cartridges. The contract has a potential value of $12,075,000 and period of performance through April 2021. Two firm fixed price delivery orders have been issued against the contract to date. The first order, valued at $4,694,575, is for SARS-COV-2 cartridges for Cepheid machines to be delivered to multiple Army medical treatment facilities from...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide COVID-19 testing equipment, supplies, and associated services to support the agency's pandemic response efforts. The initial BPA call was awarded on August 29, 2020 for COVID-19 testing stations and kits, with a potential value of $0 and a completion date of August 28, 2021. A subsequent BPA call for nucleic acid testing of...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) master contract between the Defense Health Agency (DHA) and Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $8,000,000 and an ultimate completion date of January 24, 2030. Under this single-award BPA, Cepheid provides the DHA with reagents, testing kits, and consumable supplies for molecular diagnostic testing. Key products include GeneXpert diagnostic systems,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded Cepheid a single award indefinite delivery contract with a potential value of $1.4 million to provide COVID-19, influenza, and respiratory syncytial virus (RSV) plus SARS-CoV-2 diagnostic test kits. The contract has a last order date of April 30, 2028 and aims to procure test kits that are compatible with Cepheid instrumentation owned by the VA facility in Harlingen, Texas. Under this...
This federal Indefinite Delivery Contract (IDC) with a ceiling value of $49,000,000 was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract enables the continuous procurement of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support clinical testing programs across various federal agencies, including the Department of Veterans Affairs...
This is a single-award Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The contract, valued at $900,000.00, is for the provision of SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) test kits. The awarded task order, valued at $197,065.00, is for the delivery of SARS-CoV-2 IgG testing services to the VA's Veterans Integrated...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 has awarded a Blanket Purchase Agreement (BPA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide CEPHEID REAGENTS, TEST KITS AND SUPPLIES. This single-award IDV contract has a ceiling value of $9,061,670.00 and a period of performance through September 30, 2025. The contract does not have a set-aside designation. Under this BPA, the VA has placed several task orders for Cepheid to...
  • SPE2DE22D0017
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Defense Logistics Agency Troop Support Medical awarded a single award Indefinite Delivery Contract to Cepheid, with a potential value of $790,119,750.00, to provide point-of-care nucleic acid amplification tests and analyzers. A $340 million firm fixed price delivery order was issued to Cepheid for their XPERT XPRESS SARS-COV-2/FLU/R tests, to be performed in Sunnyvale, California from April 1, 2022 through January 3, 2023.

The originating solicitation sought proposals for multiple Indefinite Delivery-Indefinite Quantity contracts for single-plex and multi-plex point-of-care nucleic acid amplification tests and analyzers. The solicitation specified tests must be FDA approved, 510(K) cleared, or authorized by EUA. The agency estimated a need for 9 million single-plex tests, 2,250 analyzers, and 5 million multi-plex tests capable of detecting SARS-CoV-2, influenza A and B, and respiratory syncytial virus within one hour. Delivery to various DLA distribution centers in the continental United States was required within ten days of order placement. Evaluation criteria included tests and analyzers meeting specifications outlined in the solicitation.

Generated 1/4/24, 9:24 PM